Human antenatal corticosteroid therapy independent of preterm birth programmes cardiac dysfunction and fibrosis in ovine adult offspring
Using a term-born ovine model to isolate the effects of antenatal corticosteroids from prematurity, this study demonstrates that fetal glucocorticoid exposure directly causes persistent cardiac dysfunction and fibrosis in adult offspring, establishing it as an independent driver of long-term cardiovascular risk.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every year, doctors administer a powerful class of medicines called corticosteroids to pregnant women who face the risk of delivering their babies too early. These drugs act like a fast-forward button for a fetus's development, specifically helping the lungs mature so the newborn can breathe on its own. This treatment has saved countless lives and is considered one of the most effective interventions in modern obstetrics. However, a shadow of uncertainty has lingered over this success. While the immediate benefits for premature infants are undeniable, scientists have long wondered if these drugs might leave behind hidden scars on the heart and blood vessels as the child grows into adulthood. The difficulty in answering this question lies in the fact that premature birth itself is a major stressor on the developing body. It has been nearly impossible to tell whether heart problems in later life stem from being born too soon or from the very medicine used to save the baby.
To untangle this knot, researchers turned to a model that mirrors human pregnancy with remarkable precision: the sheep. In a study designed to isolate the effects of the medication from the effects of early birth, scientists gave pregnant ewes a clinically relevant dose of dexamethasone, a common corticosteroid. Crucially, they used a specific technique to ensure the lambs were born at full term, just like a healthy human baby, rather than prematurely. This allowed the team to observe the long-term consequences of the drug exposure alone, free from the confounding variables of a rushed birth. The researchers then tracked these animals from their time as fetuses through to adolescence, a stage equivalent to human teenage years, to see how their cardiovascular systems had changed.
The investigation revealed that the drug triggers a cascade of changes that begin almost immediately. Within hours of the mother receiving the injection, the fetal blood vessels in the legs tightened, causing a temporary rise in blood pressure. This was not a fleeting reaction; the blood vessels themselves began to remodel, becoming thicker and less elastic, while accumulating signs of cellular stress. By the time the fetuses reached full term, their hearts were already showing signs of strain. They struggled to pump blood with full force and had difficulty relaxing between beats, a condition known as dysfunction. At this stage, however, the heart muscle itself looked normal, with no visible scarring or structural damage, suggesting the problem lay in how the heart cells were functioning rather than their physical shape.
The most striking findings emerged when the researchers examined the offspring as adolescents, nine to eleven months after birth. Despite being born at full term and having normal blood pressure, these animals carried the memory of their early drug exposure. Their hearts were stiffer and less efficient than those of the control group. They pumped less blood with each beat and had a harder time filling up with blood between beats. When the researchers looked closely at the tissue, they found the heart muscle and the major artery leading out of the heart were filled with excess fibrous tissue, a type of internal scarring that makes the organ rigid. This fibrosis explained why the hearts were struggling; they were physically stiff, unable to stretch and squeeze with the necessary ease.
The study also uncovered how these young animals were compensating for their stiff hearts. Their nervous systems had become hyper-alert, constantly signaling the heart to beat faster and harder to maintain normal blood flow. Furthermore, their blood vessels had become unusually sensitive to a natural chemical that helps them relax, suggesting the body was working overtime to keep blood pressure stable against the underlying stiffness. Importantly, the researchers found no evidence that the drug caused high blood pressure in the adolescents, a finding that aligns with human data showing that adults exposed to these drugs as fetuses often have normal blood pressure. This suggests that the danger lies not in a rise in pressure, but in a silent, structural weakening of the heart itself.
These results challenge the assumption that the risks of antenatal corticosteroids are solely tied to premature birth. The study demonstrates that the drug itself, even when given to a pregnancy that goes to full term, can program the heart for dysfunction and scarring that persists into adulthood. While the life-saving benefits of the treatment for premature infants remain unquestioned, these findings indicate that the current dosing regimens might need refinement. The researchers suggest that lower doses or combining the steroid with antioxidants could potentially preserve the lung benefits while sparing the developing heart from these long-term changes. The work highlights a complex trade-off in modern medicine, where a treatment that secures a baby's first breath may inadvertently set the stage for a heart that works harder than it should for the rest of its life.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.